Revvity Blog
Powering innovation from discovery to cure.
Latest
How conditional bispecific antibodies are advancing precision immunotherapy.
Cancer
August 14, 2025 - 2 min read
Small Molecule Drug Discovery
Impact of FGFRs dysregulation in oncogenic mechanisms.
June 6, 2024 -
4 min read
Small Molecule Drug Discovery
Disrupting protein-protein interactions in the viral life cycle: the contribution of tr-FRET.
June 6, 2024 -
3 min read
Small Molecule Drug Discovery
Deciphering TREM2’s role in Alzheimer’s disease.
June 6, 2024 -
4 min read
Small Molecule Drug Discovery
Strategies for success: Developing safe and effective commercial cell lines.
June 6, 2024 -
2 min read
Small Molecule Drug Discovery
When AlphaLISA and HTRF meet inflammatory bowel disease research needs.
June 5, 2024 -
4 min read
Disease Research
The potential of subset-specific treatment options to overcome cancer resistance.
June 4, 2024 -
2 min read
Small Molecule Drug Discovery
3 steps for successful tumor xenograft analysis.
June 3, 2024 -
3 min read
Small Molecule Drug Discovery
The evolving role of cell counting in drug discovery.
May 30, 2024 -
2 min read
Drug Development
Drug repurposing for antiviral therapies: research and strategies with high throughput screening.
May 29, 2024 -
2 min read